ClinicalTrials.gg
Not yet recruitingNCT07926100WOUND-REPORTUpdated Nov 9, 2026

Recognizing and Reporting Surgical Wound Complications After Discharge From Gastrointestinal Surgery in Egypt

An observational study in Surgical Wound Infection, sponsored by Alexandria University. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Alexandria University · Observational

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
51
Ages
18 Years and older
Sex
All
01

Study summary

Many wound problems after surgery on the digestive system, including wound infection, are first noticed after the patient has already gone home. Delays in noticing a problem and contacting the hospital can delay treatment. Existing studies come mostly from high-income countries and usually look at only one group of people. No study from Egypt or the Arabic-speaking region was found in the sources reviewed.

This qualitative study will explore what helps and what gets in the way when patients, family caregivers, and nurses recognize, report, and respond to surgical wound problems after discharge from gastrointestinal surgery. Individual semi-structured interviews will be held in Egyptian Arabic, in person or by telephone, at three hospitals in Egypt. The planned participants are 20 patients discharged 2 to 6 weeks earlier, 12 family caregivers, 15 nurses, and up to 4 key informants, for a planned total of 51. Participants will be chosen purposefully to include a wide range of experiences, and recruitment in each group will stop once further interviews bring no new themes.

Interviews will be analysed with reflexive thematic analysis, guided by the Common-Sense Model of Self-Regulation. The main result is a description of the barriers and enablers. Further results are a model of the pathway from noticing a wound change, to reporting it, to the nursing response, and a set of requirements for a nurse-led remote follow-up service.

02

Conditions studied

  • Surgical Wound Infection

Keywords

  • Surgical Site Infection
03

In context

Surgical Wound Infection

745 studies on the registry are indexed under Surgical Wound Infection; 151 are open to participants now.

This study's planned enrollment of 51 is below the median of 239 across 135 observational studies indexed under Surgical Wound Infection.

Browse Surgical Wound Infection studies →

Lead sponsor

Alexandria University is the lead sponsor of 604 studies on the registry; 140 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients discharged 2 to 6 weeks earlier after gastrointestinal surgery, their family caregivers, registered nurses, and key informants responsible for discharge or follow-up policy, at three hospitals in Egypt.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients: age 18 years or older
  • Patients: discharged 2 to 6 weeks before the interview after gastrointestinal surgery (colon, rectum, stomach, small bowel, liver and biliary tract, pancreas, gallbladder) with an abdominal wound (open or laparoscopic)
  • Patients: Arabic-speaking
  • Patients: able to give
  • Family caregivers: age 18 years or older
  • Family caregivers: the family member most involved in the patient's wound care or communication with the hospital after discharge
  • Family caregivers: Arabic-speaking
  • Nurses: registered nurses working in gastrointestinal or general surgical wards, discharge planning, or infection prevention at a study site
  • Nurses: at least 1 year of surgical or infection-prevention experience
  • Key informants: nursing managers, infection-control leads, or surgeons with responsibility for discharge or follow-up policy

Exclusion criteria

Exclusion Criteria:

  • Patients: cognitive impairment or inability to take part in an interview
  • Patients: still hospitalized or readmitted at the time of interview
  • Patients: day-case procedures without an abdominal wound requiring home care
  • Family caregivers: paid or professional caregivers
  • Nurses: on leave for the whole data collection period
  • Nurses: in direct line management of the interviewer
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
51 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients

    Adults (18 years or older) discharged 2 to 6 weeks before interview after gastrointestinal surgery with an abdominal wound; planned n = 20. Interviewed once.

  • Family Caregivers

    Adult family member most involved in the patient's wound care or communication with the hospital after discharge; planned n = 12. Interviewed once.

  • Nurses

    Registered nurses in gastrointestinal or general surgical wards, discharge planning, or infection prevention, with at least 1 year of experience; planned n = 15. Interviewed once.

06

What researchers measure

Primary outcomes

  1. Barriers and Enablers to Recognizing, Reporting, and Responding to Post-Discharge Surgical Wound Complications

    Individual, relational, and service-level barriers and enablers described by patients, caregivers, nurses, and key informants in semi-structured interviews and identified through reflexive thematic analysis. This is a qualitative outcome with no numeric scale; results are reported as themes.

    Time frame: Interviews from 10 November 2026 to 24 February 2027 (14 weeks), extendable by up to 4 weeks if the stopping rule is not met

Secondary outcomes

  1. Pathway Model From Noticing to Nursing Response

    Model of the stages of noticing a wound change, judging concern, reporting, nurse triage, and follow-up, built from the themes and mapped to the Common-Sense Model of Self-Regulation.

    Time frame: Through analysis, up to 31 March 2027

07

Study locations

1 site
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07926100
Responsible party
Mohamed Fakhry Ahmed Salem (dr, Alexandria University) — Principal investigator
First posted
Nov 9, 2026
Start date
Nov 10, 2026 (estimated)
Primary completion
Feb 24, 2027 (estimated)
Completion
Feb 24, 2027 (estimated)
Last update
Nov 9, 2026

Study contacts

Mohamed Fakhry Ahmed Salem, PhD
Contact
Mohamed.Fakhry@alexu.edu.eg
01286038014
Mohamed Fakhry Ahmed Salem, PHD
principal investigator · Alexandria University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion